FIND OUT MORE ABOUT ParticipatING in AN eczema research study
Heading 6
Researchers at UC San Francisco are conducting a research study to better understand skin inflammation in patients with atopic dermatitis (eczema).
Who can participate?
Adults (18-70 years old) who:
-
Have a physician-confirmed diagnosis of childhood-onset atopic dermatitis (eczema)
-
Are currently receiving Dupixent® (dupilumab) prescribed by their healthcare provider
Study participation will require validation of drug treatment
What would I have to do to participate?
-
Participants will first complete a brief screening call that takes less than 5 minutes
-
After research personnel validate the screening information, qualifying participants may be asked to come in for 1 in-person visit at UCSF Dermatology (~40 minutes) and an optional brief second visit
Compensation: Qualifying participants will receive up to $500 in compensation, in the form of a Visa gift card, for completing the study visit(s)
Take our pre-screening survey below. Alternatively, you can text or call us at 415-489-0186 for additional information, or email rashes@ucsf.edu with the subject "Dupi Eczema Study".
Select this paragraph to add your own text. Just drag and drop or click here to add this paragraph to your site, then you can add your own content and make changes to the font.